Linaclotide Dosage Guide
Complete guide to Linaclotide dosing protocols, administration methods, and safety considerations for research purposes.
Detailed Dosage Information
Prescription-only medicine.
Dosing is set by a physician according to the FDA-approved label and the condition being treated.
Administration Method
Administration details not available for this peptide.
Research Backing
FDA prescribing information (Linzess). Phase 3 trials in IBS-C and chronic idiopathic constipation.
Side Effects to Monitor
Diarrhea is the most common side effect, followed by abdominal pain, bloating and flatulence.
Safety Considerations & Risks
Contraindicated in children under 2 because of the risk of serious dehydration, and in known or suspected mechanical bowel obstruction. Severe diarrhea can occur and may require stopping treatment.